DAYMARK WEALTH PARTNERS, LLC

Position in TGTX — Tg Therapeutics, Inc.

CIK 1956824 CINCINNATI, OH

Position in TGTX

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$3,067,519

+$1,216,800 QoQ

Shares Held

55,834

+0.2% QoQ

Ownership

0.036%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#120

of 425 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

DAYMARK WEALTH PARTNERS, LLC holds $5,277,793 across 8 Biotechnology names. TGTX ranks #1 (58.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TGTX	Tg Therapeutics, Inc. This page	55,834	$3,067,519
2	VRTX	Vertex Pharmaceuticals Inc / Ma	1,193	$592,598
3	NUVB	Nuvation Bio Inc.	56,734	$322,249
4	VKTX	Viking Therapeutics, Inc.	8,000	$312,080
5	MRNA	Moderna, Inc.	4,103	$287,333
6	RPRX	Royalty Pharma plc	4,568	$256,127
7	EXEL	Exelixis, Inc.	4,186	$227,760
8	ROIV	Roivant Sciences Ltd.	5,994	$212,127

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,067,519	55,834	+0.2%	Shares	Sole	2026-07-31
2026-03-31	$1,850,719	55,711	+12.5%	Shares	Sole	2026-05-11
2025-12-31	$1,476,429	49,528	+0.1%	Shares	Sole	2026-01-12
2025-09-30	$1,788,187	49,500	+8.8%	Shares	Sole	2025-10-22
2025-06-30	$1,637,545	45,500	0.0%	Shares	Sole	2025-08-04
2025-03-31	$1,794,065	45,500	+9.6%	Shares	Sole	2025-04-23
2024-12-31	$1,249,150	41,500	+1.7%	Shares	Sole	2025-01-17
2024-09-30	$954,569	40,811	+73.7%	Shares	Sole	2024-10-08
2024-06-30	$418,065	23,500	0.0%	Shares	Sole	2024-08-14
2024-03-31	$357,435	23,500	+74.1%	Shares	Sole	2024-04-10
2023-12-31	$230,580	13,500	0.0%	Shares	Sole	2024-01-09
2023-09-30	$112,860	13,500	—	Shares	Sole	2023-10-10
No filing history on record for this holder in this stock.